Copyright ©The Author(s) 2022.
World J Hepatol. Dec 27, 2022; 14(12): 1985-1996
Published online Dec 27, 2022. doi: 10.4254/wjh.v14.i12.1985
Figure 1
Figure 1 Combination therapy for hepatocellular carcinoma. Top: Conventional treatment may lead to tumour recurrence due to cancer stem cell reactivation. Bottom: Combination therapy leads to increased efficacy of tumour eradication. Adapted from Dzobo et al[8]. HCC: Hepatocellular carcinoma; CSC: Cancer stem cell.
Figure 2
Figure 2 Liver cancer stem cells markers and their potential related functional pathways in hepatocellular carcinoma. HCC: Hepatocellular carcinoma; LCSCs: Liver cancer stem cells.